Evaluation of Pain Treatment After Total Knee Arthroplasty
Phase 4 – monitoring after market approval
Conditions:
Pain
Sponsor: Vertex Pharmaceuticals Incorporated
trial.available_in:
БГ
Overview
The purpose of the study is to characterize opioid use after total knee arthroplasty (TKA).
Who can participate
Key Inclusion Criteria:
* Body mass index (BMI) of greater than or equal to (≥) 18.0 to less than or equal to (≤) 40.0 kilogram per meter square (kg/m\^2)
* Scheduled to undergo an elective primary unilateral TKA surgery
Key Exclusion Criteria:
\- History of previous TKA surgery on incident side
Other protocol defined Inclusion/Exclusion criteria will apply.
БГ